Achilles Therapeutics plc

Achilles Therapeutics plcverified

ACHL

Price:

$0.7838

Market Cap:

$32.20M

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therap...[Read more]

Industry

Biotechnology

IPO Date

2021-03-31

Stock Exchange

NASDAQ

Ticker

ACHL

The PE Ratio as of April 2024 (TTM) for Achilles Therapeutics plc (ACHL) is -0.45

According to Achilles Therapeutics plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.45. This represents a change of -15.28% compared to the average of -0.53 of the last 4 quarters.

Achilles Therapeutics plc (ACHL) Historical PE Ratio (quarterly & annually)

How has ACHL PE Ratio performed in the past?

The mean historical PE Ratio of Achilles Therapeutics plc over the last ten years is -5.11. The current -0.45 PE Ratio has changed 780.79% with respect to the historical average. Over the past ten years (40 quarters), ACHL's PE Ratio was at its highest in in the December 2022 quarter at -0.37. The PE Ratio was at its lowest in in the March 2019 quarter at -21.53.

Quarterly (TTM)
Annual

Average

-5.11

Median

-1.94

Minimum

-20.25

Maximum

-0.49

Achilles Therapeutics plc (ACHL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Achilles Therapeutics plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 942.54%

Maximum Annual PE Ratio = -0.49

Minimum Annual Increase = -88.40%

Minimum Annual PE Ratio = -20.25

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.512.67%
2022-0.49-78.94%
2021-2.35-88.40%
2020-20.25942.54%

Achilles Therapeutics plc (ACHL) Average PE Ratio

How has ACHL PE Ratio performed in the past?

The current PE Ratio of Achilles Therapeutics plc (ACHL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.12

5-year avg

-5.11

10-year avg

-5.11

Achilles Therapeutics plc (ACHL) PE Ratio vs. Peers

How is ACHL’s PE Ratio compared to its peers?

Achilles Therapeutics plc’s PE Ratio is greater than Assembly Biosciences, Inc. (-1.22), less than Spero Therapeutics, Inc. (3.17), less than Instil Bio, Inc. (-0.45), greater than Neoleukin Therapeutics, Inc. (-0.98), greater than Nuvation Bio Inc. (-8.20), less than CytomX Therapeutics, Inc. (61.88), greater than NextCure, Inc. (-0.65),

Build a custom stock screener for Achilles Therapeutics plc (ACHL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achilles Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achilles Therapeutics plc (ACHL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achilles Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Achilles Therapeutics plc's PE Ratio?

How is the PE Ratio calculated for Achilles Therapeutics plc (ACHL)?

What is the highest PE Ratio for Achilles Therapeutics plc (ACHL)?

What is the 3-year average PE Ratio for Achilles Therapeutics plc (ACHL)?

What is the 5-year average PE Ratio for Achilles Therapeutics plc (ACHL)?

How does the current PE Ratio for Achilles Therapeutics plc (ACHL) compare to its historical average?